Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'st 836 hydrochloride'

Search results for: 'st 836 hydrochloride'

Items 101-110 of 631

Page
per page
  1. Zoniporide (hydrochloride)
    C3480 Zoniporide (hydrochloride)
    Summary: sodium-hydrogen exchanger isoform-1 (NHE-1) inhibitor
      ≤1 mg/mL
  2. Kanosamine (hydrochloride)
    C3461 Kanosamine (hydrochloride)
    Summary: antibiotic
      ≤5 mg/mL
  3. AD57 (hydrochloride)
    C3080 AD57 (hydrochloride)
    Summary: polypharmacological cancer therapeutic that inhibits RET.
      ≤5 mg/mL
  4. Ulixertinib (hydrochloride)
    C3921 Ulixertinib (hydrochloride)
    Summary: reversible ERK1/2 inhibitor
      insoluble in H2O; ≥20.15 mg/mL
  5. Clorgyline (hydrochloride)
    C4137 Clorgyline (hydrochloride)
    Summary: MAO-A inhibitor
      ≥17.65 mg/mL
  6. Celiprolol (hydrochloride)
    C4521 Celiprolol (hydrochloride)
    Summary: β1 adrenergic receptor antagonist and β2 adrenergic receptor partial agonist
      ≤2 mg/mL
  7. VU590 (hydrochloride)
    C4778 VU590 (hydrochloride)
    Summary: inhibitor of KCNJ1
      ≤20 mg/mL
  8. Bufuralol (hydrochloride)
    C5043 Bufuralol (hydrochloride)
    Summary: non-specific β-adrenergic blocker
      ≤15 mg/mL
  9. AN3365 (hydrochloride)
    C5068 AN3365 (hydrochloride)
    Summary: potent and selective leucyl-tRNA synthetase inhibitor
      ≤10 mg/mL
  10. Calindol (hydrochloride)
    C5329 Calindol (hydrochloride)
    Summary: activator of the calcium-sensing receptor (CaSR)
      ≤15 mg/mL

Items 101-110 of 631

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 530item
  2. Natural Products 15item
  3. Amino Acids & Building Blocks 1 item
  4. Screening Library 33item
  5. Probes & Dyes 2item
  6. Protein & Immunology 2item
  7. Lab Reagents 15item
Specificity
  1. Selective 38item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. GSK-3 1 item
  11. VEGFR 1 item
  12. PDGFR 1 item
  13. c-Kit 1 item
  14. Phosphodiesterases (PDEs) 2item
  15. p38 1 item
  16. GABAB Receptors 1 item
  17. Sir2-like Family Deacetylases (Sirtuins) 1 item
  18. Aminopeptidases 1 item
  19. EGFR 2item
  20. FAK 1 item
  21. Syk 1 item
  22. DNA-PK 1 item
  23. HSP90 1 item
  24. AMPK 1 item
  25. Gutathione S-transferase 1 item
  26. Topoisomerases 1 item
  27. Serine Proteases 1 item
  28. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  29. Pyk2 1 item
  30. 5-HT2 Receptors 2item
  31. S1P receptors 1 item
  32. ALK 1 item
  33. Myosin light chain kinases (MLCKs) 1 item
  34. 5-HT3 Receptors 2item
  35. Angiotensin-Converting Enzymes (ACEs) 1 item
  36. Squalene epoxidases 3item
  37. Nampt 1 item
  38. Glutamate (Metabotropic) Group I Receptors 1 item
  39. Urokinases 1 item
  40. Histamine H1 Receptors 1 item
  41. Sigma Receptors 1 item
  42. Apoptosis Inducers 1 item
  43. AChE 1 item
  44. Inward Rectifier Potassium (Kir) Channels 1 item
  45. c-RET 1 item
  46. guanylyl cyclase 1 item
  47. dopamine receptor 1 item
  48. 5-HT1 Receptor 2item
  49. 5-HT2 Receptor 1 item
  50. NMPRTase 1 item
  51. IKK 1 item
  52. Antibiotic 1 item
  53. Calmodulins 1 item
  54. Calcium-Sensing Receptors (CaSRs) 2item
  55. PAR receptor 1 item
  56. TRPC channel 1 item
  57. GABAA receptor 1 item
  58. CRF1 Receptors 1 item
Reported Experiments
  1. Animal Experiments 61item
  2. Cell Experiments 58item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 3item
  5. Cancer 19item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 3item
  8. Colorectal Cancer 2item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 2item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 1 item
  15. Lung Cancer 3item
  16. Multidrug Resistance Studies 1 item
  17. Multiple Myeloma 2item
  18. Narcolepsy 1 item
  19. Non-small Cell Lung Cancer 1 item
  20. Pancreatic Cancer 2item
  21. Prostate Cancer 3item
  22. Schizophrenia 1 item
  23. Type 2 Diabetes 1 item